Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
3-year Survival
10%
Age at Diagnosis
10%
Allogeneic
100%
Allogeneic Transplantation
100%
Autologous Transplantation
100%
Chemosensitivity
10%
Conditioning Regimen
10%
Disease Progression
10%
Early Mortality
10%
Median Time
30%
Multiple Myeloma
100%
Neutrophil Engraftment
10%
Overall Survival
30%
Platelet Engraftment
10%
Progression-free Survival
20%
Published Results
10%
Retrospective Analysis
10%
Safe Procedure
10%
Single Center
100%
Syngeneic Transplantation
10%
Medicine and Dentistry
Allograft
100%
Autotransplantation
100%
Chemosensitivity
25%
Disease Exacerbation
25%
Engraftment
50%
Graft Versus Host Reaction
25%
Median Follow Up
25%
Multiple Myeloma
100%
Neutrophil
25%
Overall Survival
100%
Platelet
25%
Progression Free Survival
50%
Immunology and Microbiology
Allograft
100%
Autotransplantation
100%
Chemosensitivity
25%
Engraftment
50%
Graft-Versus-Host Disease
25%
Multiple Myeloma
100%
Neutrophil
25%
Overall Survival
100%
Platelet
25%
Progression Free Survival
50%
Syngenic
25%